Abstract
Background
Artificial intelligence (AI) has made great strides. Our study evaluated the performance in delivering clinical questions related to autoimmune diseases (AIDs).
Methods
46 AIDs-related questions were compiled and entered into ChatGPT 3.5, ChatGPT 4.0, and Gemini. The replies were collected and sent to laboratory specialists for scoring according to relevance, correctness, completeness, helpfulness, and safety. Scores for three chatbots in five quality dimensions and the scores of the replies to the questions under each quality dimension were analyzed.
Results
ChatGPT 4.0 showed superior performance than ChatGPT 3.5 and Gemini in all five quality dimensions. ChatGPT 4.0 outperformed ChatGPT 3.5 or Gemini on the relevance, completeness or helpfulness in answering about the prognosis, diagnosis, or the report interpretation of AIDs. ChatGPT 4.0’s replies were the longest, followed by ChatGPT 3.5, Gemini’s was the shortest.
Conclusions
Our findings highlight ChatGPT 4.0 is superior to delivering comprehensive and accurate responses to AIDs-related clinical questions.